Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

CRISPR01:59

CRISPR

50.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.2K
RNA Editing02:23

RNA Editing

9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.0K
Overview
74.0K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
Gene Therapy00:59

Gene Therapy

25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1<sup>R671C/-</sup> mice.

EMBO molecular medicine·2026
Same author

Proceedings of the second annual meeting of GenE-HumDi (COST Action 21113).

Frontiers in genome editing·2025
Same author

From Radiocopper to Cold Copper: Mechanistic Modeling and Simulation to Define Clinical Response Criteria and Biomarkers for VTX-801 in Wilson Disease.

CPT: pharmacometrics & systems pharmacology·2025
Same author

In Vivo Selection of S/MAR Sequences to Favour AAV Episomal Maintenance in Dividing Cells.

International journal of molecular sciences·2024
Same author

E2A, VA RNA I, and L4-22k adenoviral helper genes are sufficient for AAV production in HEK293 cells.

Molecular therapy. Methods & clinical development·2024
Same author

Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates.

Vaccines·2024

相关实验视频

Updated: Jun 18, 2025

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes
09:45

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes

Published on: June 2, 2022

2.6K

在肝脏疾病中基因编辑.

Laura Torella1, Nerea Santana-Gonzalez1, Nerea Zabaleta2

  • 1DNA & RNA Medicine Division, Gene Therapy for Rare Diseases Department, Center for Applied Medical Research (CIMA), University of Navarra, IdisNA, Pamplona, Spain.

FEBS letters
|July 30, 2024
PubMed
概括

基因编辑技术,如CRISPR Cas9,通过修改基因组,为治疗遗传性肝病提供了新的途径. 早期的临床结果显示出有希望,但需要对疗效和限制进行更多研究.

关键词:
基因编辑 临床研究 临床研究基因编辑 临床前研究基因编辑工具是基因编辑工具.遗传性肝脏疾病 遗传性肝脏疾病肝脏基因输送车辆 肝脏基因输送车辆

更多相关视频

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.1K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.8K

相关实验视频

Last Updated: Jun 18, 2025

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes
09:45

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes

Published on: June 2, 2022

2.6K
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.1K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

33.8K

科学领域:

  • 遗传学和基因组学 遗传学和基因组学
  • 分子生物学分子生物学
  • 医学生物技术 医学生物技术

背景情况:

  • 工程核酶使得精确的宿主基因组修改成为可能,进步了现代医学.
  • 克里斯普 Cas9 技术在体内基因编辑方面进行了革命,用于治疗应用.
  • 对代谢性肝脏疾病的临床试验显示出有前途的结果,特别是在transthyretin amyloidosis.

研究的目的:

  • 对遗传性肝病的动物模型中基因编辑的临床前数据进行审查.
  • 总结有关肝脏疾病基因编辑疗法的当前临床数据.
  • 强调这些干预措施的治疗效果和潜在限制.

主要方法:

  • 在动物模型中进行基因编辑的临床前研究的审查.
  • 对基因编辑疗法的临床试验数据的分析.
  • 合成关于基因补充,校正和沉默策略的信息.

主要成果:

  • 基因编辑显示出治疗代谢性肝脏疾病的潜力.
  • 转氨基粉症患者在使用这些疗法时表现出了显著的结果.
  • 在体内基因组修改提供了多种不同的治疗可能性.

结论:

  • 基因编辑对遗传性肝脏疾病具有显著的治疗潜力.
  • 进一步的研究对于充分了解基因编辑干预的有效性和局限性至关重要.
  • 该领域正在迅速发展,未来几年预计将取得进展.